Our present study demonstrate that M-CSF/CSF-1R signaling represents a further link between microglial inflammation and diabetic retinopathy and raises the possibility of specific therapies for targeting microglia-mediated injury in diabetic retinopathy. The gene discussed is CSF1R; the disease is diabetic retinopathy.